Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0293 USD | -2.33% | -7.28% | -95.82% |
May. 30 | First Motion for Exclusivity Period Extension Filed by DMK Pharmaceuticals Corporation | CI |
May. 08 | Motion for Asset Sale Approved for DMK Pharmaceuticals Corporation | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe1st Jan change | Capi. | |
---|---|---|
-95.82% | 296K | |
+48.39% | 779B | |
-6.13% | 354B | |
+20.61% | 333B | |
+10.00% | 301B | |
+18.35% | 249B | |
-2.04% | 216B | |
+11.26% | 214B | |
+5.80% | 163B | |
-2.50% | 159B |
- Stock Market
- Equities
- DMKPQ Stock
- News DMK Pharmaceuticals Corporation
- Transcript : Adamis Pharmaceuticals Corporation, Q3 2022 Earnings Call, Nov 14, 2022